Skip to main content

Recursion Pharmaceuticals, Inc.

RXRX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001601830

In the last 90 days, Recursion Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 4 sales; 344 institutions reported holding it in 13F filings for Q2 2026, worth $1.33B in total; ARK Invest is the only superinvestor holding it.

13F holders, Q1 2025

Institutional positions in Recursion Pharmaceuticals, Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
337
+23 vs. Q4 2024
Shares held
307.6M
+3.99M (+1.3%) vs. Q4 2024
Total value
$1.63B
−$425.7M (−20.7%) vs. Q4 2024
New holders
66
137 more added
Sold out
43
71 more reduced

2 institutions that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q4 2024: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting RXRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2025: 337 institutions
Q1 2021: 1 institutionQ2 2021: 75 institutionsQ3 2021: 84 institutionsQ4 2021: 126 institutionsQ1 2022: 128 institutionsQ2 2022: 133 institutionsQ3 2022: 146 institutionsQ4 2022: 144 institutionsQ1 2023: 159 institutionsQ2 2023: 158 institutionsQ3 2023: 192 institutionsQ4 2023: 199 institutionsQ1 2024: 248 institutionsQ2 2024: 270 institutionsQ3 2024: 268 institutionsQ4 2024: 316 institutionsQ1 2025: 337 institutionsQ2 2025: 333 institutionsQ3 2025: 322 institutionsQ4 2025: 335 institutionsQ1 2026: 335 institutionsQ2 2026: 344 institutions
Value heldQ1 2025: $1.63B
Q1 2021: $1.00KQ2 2021: $1.71BQ3 2021: $1.26BQ4 2021: $1.62BQ1 2022: $680.3MQ2 2022: $861.1MQ3 2022: $1.21BQ4 2022: $954.0MQ1 2023: $841.4MQ2 2023: $952.8MQ3 2023: $1.16BQ4 2023: $2.04BQ1 2024: $2.12BQ2 2024: $1.89BQ3 2024: $1.74BQ4 2024: $2.06BQ1 2025: $1.63BQ2 2025: $1.57BQ3 2025: $1.58BQ4 2025: $1.33BQ1 2026: $1.03BQ2 2026: $1.33B
Institutions holding RXRX and their total value by quarter
QuarterHoldersValue
Q2 2026344$1.33B
Q1 2026335$1.03B
Q4 2025335$1.33B
Q3 2025322$1.58B
Q2 2025333$1.57B
Q1 2025337$1.63B
Q4 2024316$2.06B
Q3 2024268$1.74B
Q2 2024270$1.89B
Q1 2024248$2.12B
Q4 2023199$2.04B
Q3 2023192$1.16B
Q2 2023158$952.8M
Q1 2023159$841.4M
Q4 2022144$954.0M
Q3 2022146$1.21B
Q2 2022133$861.1M
Q1 2022128$680.3M
Q4 2021126$1.62B
Q3 202184$1.26B
Q2 202175$1.71B
Q1 20211$1.00K

Institutions, Q1 2025

Shares, value and share of portfolio for each institution holding Recursion Pharmaceuticals, Inc.; share changes are against Q4 2024.

Institutions holding RXRX in Q1 2025
InstitutionSharesValue% of portfolioChange in sharesAction
Vestmark Advisory Solutions, Inc.706,239$3.74M0.10%−138,915−16.4%Reduced
JPMorgan Chase & Co818,324$4.33M0.00%−238,843−22.6%Reduced
Bank of New York Mellon Corp863,224$4.57M0.00%+12,588+1.5%Added
Comprehensive Financial Management LLC941,895$4.98M0.16%00.0%Unchanged
First Trust Advisors LP1,031,499$5.46M0.00%+1,031,499New
Two Sigma Investments, LP1,152,626$6.10M0.01%−507,883−30.6%Reduced
Bank of America Corp1,284,962$6.80M0.00%+402,098+45.5%Added
Goldman Sachs Group Inc1,495,863$7.91M0.00%−569,345−27.6%Reduced
Laurion Capital Management LP1,547,407$8.19M0.63%−909,782−37.0%Reduced
Dimensional Fund Advisors LP1,716,775$9.09M0.00%+8,735+0.5%Added
Nuveen, LLC1,912,620$10.1M0.00%+1,912,620New
Susquehanna International Group, LLP2,049,611$10.8M0.02%+382,622+23.0%Added
Charles Schwab Investment Management Inc2,278,401$12.1M0.00%+4,398+0.2%Added
Northern Trust Corp2,395,188$12.7M0.00%+6770.0%Added
Citadel Advisors LLC2,655,711$14.0M0.01%−83,536−3.0%Reduced
Norges Bank3,412,003$18.0M0.00%−53,872−1.6%Reduced
Exor Capital LLP3,675,077$19.4M0.51%00.0%Unchanged
DCVC Opportunity Fund II GP, LLC3,951,141$20.9M25.65%00.0%Unchanged
Morgan Stanley5,010,433$26.5M0.00%+2,149,906+75.2%Added
UBS Group AG5,569,782$29.5M0.01%+2,565,137+85.4%Added
Data Collective IV GP, LLC5,941,120$31.4M36.17%00.0%Unchanged
UBS Asset Management Americas Inc6,408,524$33.9M0.01%+4,149,346+183.7%Added
Geode Capital Management, LLC6,443,980$34.1M0.00%+356,831+5.9%Added
FMR LLC6,846,842$36.2M0.00%−225,339−3.2%Reduced
NVIDIA Corp7,706,363$40.8M3.55%00.0%Unchanged
Nikko Asset Management Americas, Inc.8,407,334$44.4M0.57%−501,317−5.6%Reduced
Sumitomo Mitsui Trust Holdings, Inc.8,479,284$44.9M0.03%−501,317−5.6%Reduced
MIC Capital Management UK LLP9,644,032$51.0M10.39%−10.0%Reduced
Novo Holdings A/S9,665,128$51.1M3.89%−449,505−4.4%Reduced
Mubadala Investment Co PJSC12,985,927$68.7M0.39%00.0%Unchanged
State Street Corp13,085,258$69.2M0.00%+506,898+4.0%Added
Kinnevik AB (publ)13,434,171$71.1M100.00%+1,528,503+12.8%Added
Softbank Group Corp14,667,491$77.6M0.26%00.0%Unchanged
BlackRock, Inc.23,506,589$124.3M0.00%+69,953+0.3%Added
Baillie Gifford & Co24,393,015$129.0M0.11%−471,043−1.9%Reduced
Vanguard Group Inc32,287,977$170.8M0.00%−1,722,017−5.1%Reduced
ARK Investment Management LLCSuperinvestorARK Invest34,815,502$184.2M1.84%+2,469,104+7.6%Added
Activest Wealth Management0$00.00%−186−100.0%Sold out
Ra Capital Management, L.P.0$00.00%−7,725,096−100.0%Sold out
Deerfield Management Company, L.P. (Series C)0$00.00%−2,315,000−100.0%Sold out
Woodline Partners LP0$00.00%−670,867−100.0%Sold out
Institute for Wealth Management, LLC.0$00.00%−580,997−100.0%Sold out
Jane Street Group, LLC0$00.00%−352,855−100.0%Sold out
Susquehanna Fundamental Investments, LLC0$00.00%−130,443−100.0%Sold out
Caption Management, LLC0$00.00%−102,900−100.0%Sold out
XTX Topco Ltd0$00.00%−83,547−100.0%Sold out
Man Group plc0$00.00%−70,802−100.0%Sold out
Bayesian Capital Management, LP0$00.00%−66,900−100.0%Sold out
Nomura Asset Management Co Ltd0$00.00%−56,310−100.0%Sold out
Schonfeld Strategic Advisors LLC0$00.00%−54,511−100.0%Sold out
Engineers Gate Manager LP0$00.00%−46,190−100.0%Sold out
Los Angeles Capital Management LLC0$00.00%−32,755−100.0%Sold out
Bayforest Capital Ltd0$00.00%−31,781−100.0%Sold out
Sherbrooke Park Advisers LLC0$00.00%−26,230−100.0%Sold out
Titleist Asset Management, LLC0$00.00%−23,065−100.0%Sold out
Jaffetilchin Investment Partners, LLC0$00.00%−21,754−100.0%Sold out
Resolute Partners Group0$00.00%−14,670−100.0%Sold out
Central Asset Investments & Management Holdings (HK) Ltd0$00.00%−14,200−100.0%Sold out
Impact Partnership Wealth, LLC0$00.00%−13,277−100.0%Sold out
Schroder Investment Management Group0$00.00%−11,876−100.0%Sold out
International Assets Investment Management, LLC0$00.00%−11,969−100.0%Sold out
Arkadios Wealth Advisors0$00.00%−12,431−100.0%Sold out
Atria Wealth Solutions, Inc.0$00.00%−11,123−100.0%Sold out
Chicago Partners Investment Group LLC0$00.00%−10,272−100.0%Sold out
Virtus ETF Advisers LLC0$00.00%−10,185−100.0%Sold out
Thoroughbred Financial Services, LLC0$00.00%−10,000−100.0%Sold out
Financial Life Planners0$00.00%−2,986−100.0%Sold out
Tucker Asset Management LLC0$00.00%−1,442−100.0%Sold out
Financial Management Professionals, Inc.0$00.00%−840−100.0%Sold out
Skopos Labs, Inc.0$00.00%−724−100.0%Sold out
Richard W. Paul & Associates, LLC0$00.00%−424−100.0%Sold out
Quantbot Technologies LP0$00.00%−403−100.0%Sold out
Smartleaf Asset Management LLC0$00.00%−269−100.0%Sold out
Quadrant Capital Group LLC0$00.00%−143−100.0%Sold out
Catherine Avery Investment Management LLC0$00.00%−70−100.0%Sold out
Cranbrook Wealth Management, LLC0$00.00%−35−100.0%Sold out
GeoWealth Management, LLC0$00.00%−27−100.0%Sold out
Western Pacific Wealth Management, LP0$00.00%−20−100.0%Sold out
Danske Bank A/S0$00.00%−3−100.0%Sold out
NBC Securities, Inc.0$00.00%−1−100.0%Sold out
Nuveen Asset Management, LLC––––Not filed
Global Retirement Partners, LLC––––Not filed